| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020520 |
| Receipt No. | R000011657 |
| Official scientific title of the study | effect of probiotics in low birth weight infant |
| Date of disclosure of the study information | 2016/04/14 |
| Last modified on | 2016/04/15 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | effect of probiotics in low birth weight infant | |
| Title of the study (Brief title) | probiotics in low birth weight infant | |
| Region |
|
|
| Condition | ||
| Condition | low birth weight infant | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | to clarify the impact of IgA secretion on probiotics in low birth weight infant |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | measurement of IgA and IgE in serum, and sIgA in stool at birth, 1month 2 month and 6month |
| Key secondary outcomes | measurement of IgG and IgM in serum in 1month 2 month and 6month |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | viable Bifidobacterium for six months | |
| Interventions/Control_2 | heat treated Bifidobacterium for six months | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Low birth weight infant (1500g-2500g) | |||
| Key exclusion criteria | severe congenital anomaly | |||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeki Koshida |
| Organization | Shiga University of Medical Science |
| Division name | Department of Community Perinatal Medicine |
| Address | Tsukinowa cho, Seta, Ohtsu, Shiga |
| TEL | 077-548-2447 |
| koshida@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Shigeki Koshida |
| Organization | Shiga University of Medical Science |
| Division name | Department of Community Perinatal Medicine |
| Address | Tsukinowa cho, Seta, Ohtsu, Shiga |
| TEL | 077-548-2447 |
| Homepage URL | |
| koshida@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Shiga University of Medical Science |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011657 |